|
A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis.
Blood.. 2003 Oct; Epub ahead of print Oct
Saposnik B, Reny JL, Gaussem P, Emmerich J, Aiach M, Gandrille S |
|
Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin.
Proc Natl Acad Sci U S A. 2003 Oct; 100(21):12051-6.
Rezaie AR, Yang L. |
|
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial.
Blood. 2003 Oct; Epub ahead of print Sep
Kemmeren JM, Algra A, Meijers JC, Tans G, Bouma BN, Curvers J, Rosing J, Grobbee DE. |
|
The function of factor XI in tissue factor-initiated thrombin generation.
J Thromb Haemost. 2003 Oct; 1(10):2103-11.
Butenas S, Dee JD, Mann KG. |
|
Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool.
Haematologica.. 2003 Oct; 88(10):1150-6.
Christella M, Thomassen LG, Castoldi E, Tans G, Magdeleyns EJ, Delaunoit C, Debusscher L, Van Assche KJ, Rosing J. |
|
Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assay.
Thromb Haemost. 2003 Oct; 90(4):620-7.
Antovic JP, Antovic A. |
|
Interaction between oral contraceptive use and coagulation factor levels in deep venous thrombosis.
J Thromb Haemost. 2003 Oct; 1(10):2186-90.
Van Hylckama Vlieg A, Rosendaal FR. |
|
Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
Biochemistry. 2003 Sep; 42(38):11316-25.
Sheehan JP, Kobbervig CE, Kirkpatrick HM |
|
D-dimer in venous thromboembolism.
N Engl J Med. 2003 Sep; 349(13):1203-4.
Bockenstedt P. |
|
The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutation.
Blood. 2003 Sep; 102(5):1686-92. Epub 2003 May 1
Koenen RR, Tans G, van Oerle R, Hamulyak K, Rosing J, Hackeng TM |
|
Antiapoptotic effect of coagulation factor VIIa.
Blood. 2003 Sep; 102(5):1708-15. Epub 2003 May 8
Sorensen BB, Rao LV, Tornehave D, Gammeltoft S, Petersen LC. |
|
Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies.
Stroke. 2003 Sep; 34(9):2165-70. Epub 2003 Ago 7
Horstmann S, Kalb P, Koziol J, Gardner H, Wagner S |
|
Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk.
Lancet. 2003 Ago; 362(9382):428-32.
Scarabin PY, Oger E, Plu-Bureau G; EStrogen and THromboEmbolism Risk Study Group (ESTHER). |
|
Activation of platelets in whole blood by recombinant factor VIIa by a thrombin-dependent mechanism.
Br J Haematol. 2003 Ago; 122(4): 651-61.
Wilbourn B, Harrison P, Mackie IJ, Liesner R, Machin SJ |
|
Complexity of the genetic contribution to factor VII deficiency in two Spanish families: clinical and biological implications.
Haematologica. 2003 Ago; 88(8):906-13.
Sabater-Lleal M, Martinez-Marchan E, Martinez-Sanchez E, Coll M, Vallve C, Mateo J, Souto JC, Fontcuberta J, Soria JM. |
|
Does sticky blood predict a sticky end? Associations of blood viscosity, haematocrit and fibrinogen with mortality in the West of Scotland.
Br J Haematol. 2003 Ago; 122(4):645-50.
Woodward M, Rumley A, Tunstall-Pedoe H, Lowe GD. |
|
Mechanisms of Arg-Pro-Pro-Gly-Phe inhibition of thrombin.
Am J Physiol Heart Circ Physiol. 2003 Jul; 285(1):H183-H193. Epub 2003 Feb 21
Hasan AA, Warnock M, Nieman M, Srikanth S, Mahdi F, Krishnan R, Tulinsky A, Schmaier AH. |
|
Effects of recombinant factor VIIa on platelet function and clot structure in blood with deficient prothrombin conversion.
Thromb Haemost . 2003 May; 89(5):803-11.
Carr ME Jr, Martin EJ, Kuhn JG, Seremetis SV. |
|
Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells.
Blood. 2003 May; Epub ahead of print May
Takeya H, Gabazza EC, Aoki S, Ueno H, Suzuki K. |
|
Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability.
Haematologica. 2003 May; 88(5):547-54.
Chantarangkul V, Clerici M, Bressi C, Giesen PL, Tripodi A. |
